Alivus Life Sciences - Quaterly Results

23 Jan 2026 Evaluate
With no major difference for the quarter endedDecember 2025 , the total revenue stood at Rs. 6728.89  millions.The Company has registered profit of Rs. 1502.61  millions for the quarter ended December 2025, a growth of 9.71%  over Rs. 1369.60 millions millions achieved in the corresponding quarter of last year.Operating profit surged to 2452.01 millions from the corresponding previous quarter of 2007.64 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 6728.89 6418.44 4.84 18627.15 17373.39 7.22 23868.84 22832.14 4.54
Other Income 139.28 104.56 33.21 376.33 244.82 53.72 345.70 120.42 187.08
PBIDT 2452.01 2007.64 22.13 6203.87 5086.34 21.97 7171.54 6862.88 4.50
Interest 14.94 4.58 226.20 40.63 11.54 252.08 24.14 15.46 56.14
PBDT 2180.50 2003.06 8.86 5906.67 5074.80 16.39 7147.40 6847.42 4.38
Depreciation 196.58 151.59 29.68 551.57 446.39 23.56 606.09 534.52 13.39
PBT 1983.92 1851.47 7.15 5355.10 4628.41 15.70 6541.31 6312.90 3.62
TAX 481.31 481.87 -0.12 1336.88 1190.82 12.27 1685.04 1604.02 5.05
Deferred Tax -57.85 13.81 -518.90 8.85 45.19 -80.42 60.64 81.88 -25.94
PAT 1502.61 1369.60 9.71 4018.22 3437.59 16.89 4856.27 4708.88 3.13
Equity 245.36 245.07 0.12 245.36 245.07 0.12 245.07 245.05 0.01
PBIDTM(%) 36.44 31.28 16.50 33.31 29.28 13.76 30.05 30.06 -0.04

Alivus Life Sciences Share Price

882.10 20.30 (2.36%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×